P596 Trough concentration of ustekinumab was a useful biomarker for the prediction of treatment-effects in patients with Crohn’s Diseases

Saved in:
Bibliographic Details
Published in:Journal of Crohn's and colitis 2021-05, Vol.15 (Supplement_1), p.S543-S543
Main Authors: Kato, S, Yamaga, N, Ishibashi, A, Kani, K, Yakabi, K, Nagoshi, S
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page S543
container_issue Supplement_1
container_start_page S543
container_title Journal of Crohn's and colitis
container_volume 15
creator Kato, S
Yamaga, N
Ishibashi, A
Kani, K
Yakabi, K
Nagoshi, S
description
doi_str_mv 10.1093/ecco-jcc/jjab076.717
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_ecco_jcc_jjab076_717</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_ecco_jcc_jjab076_717</sourcerecordid><originalsourceid>FETCH-LOGICAL-c917-693d1b1c8bcea45b58e67c3f3eaf86a0bbd52babb7162d90f13cd2b80a5c77fa3</originalsourceid><addsrcrecordid>eNo1kEtOwzAURS0EEqWwAwbeQFq7Tux4iMpXQoJB55HtPBOnbVzZjipmzFkB22MluFBG9-lK70j3IHRNyYwSyeZgjC96Y-Z9rzQRfCaoOEETWgtelKWQp783K6Qs-Tm6iLEnpJKVqCfo87WSHK-CH986bPxgYEhBJecH7C0eY4K1G8at0nivIla5ATtusHZ-q8IaArY-4NQB3gVonfl_TAFU2mZWAdaCSRG7Ae8yN1cR713q8DL4bvj--Ir41kVQEeIlOrNqE-HqmFO0ur9bLR-L55eHp-XNc2EkFQWXrKWamlobUGWlqxq4MMwyULbmimjdVguttBaUL1pJLGWmXeiaqMoIYRWbovIPa4KPMYBtdsHlNe8NJc3BZ3Pw2WSfzdFnk32yH8q6cfs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>P596 Trough concentration of ustekinumab was a useful biomarker for the prediction of treatment-effects in patients with Crohn’s Diseases</title><source>Oxford Journals Online</source><creator>Kato, S ; Yamaga, N ; Ishibashi, A ; Kani, K ; Yakabi, K ; Nagoshi, S</creator><creatorcontrib>Kato, S ; Yamaga, N ; Ishibashi, A ; Kani, K ; Yakabi, K ; Nagoshi, S</creatorcontrib><identifier>ISSN: 1873-9946</identifier><identifier>EISSN: 1876-4479</identifier><identifier>DOI: 10.1093/ecco-jcc/jjab076.717</identifier><language>eng</language><ispartof>Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S543-S543</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Kato, S</creatorcontrib><creatorcontrib>Yamaga, N</creatorcontrib><creatorcontrib>Ishibashi, A</creatorcontrib><creatorcontrib>Kani, K</creatorcontrib><creatorcontrib>Yakabi, K</creatorcontrib><creatorcontrib>Nagoshi, S</creatorcontrib><title>P596 Trough concentration of ustekinumab was a useful biomarker for the prediction of treatment-effects in patients with Crohn’s Diseases</title><title>Journal of Crohn's and colitis</title><issn>1873-9946</issn><issn>1876-4479</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNo1kEtOwzAURS0EEqWwAwbeQFq7Tux4iMpXQoJB55HtPBOnbVzZjipmzFkB22MluFBG9-lK70j3IHRNyYwSyeZgjC96Y-Z9rzQRfCaoOEETWgtelKWQp783K6Qs-Tm6iLEnpJKVqCfo87WSHK-CH986bPxgYEhBJecH7C0eY4K1G8at0nivIla5ATtusHZ-q8IaArY-4NQB3gVonfl_TAFU2mZWAdaCSRG7Ae8yN1cR713q8DL4bvj--Ir41kVQEeIlOrNqE-HqmFO0ur9bLR-L55eHp-XNc2EkFQWXrKWamlobUGWlqxq4MMwyULbmimjdVguttBaUL1pJLGWmXeiaqMoIYRWbovIPa4KPMYBtdsHlNe8NJc3BZ3Pw2WSfzdFnk32yH8q6cfs</recordid><startdate>20210527</startdate><enddate>20210527</enddate><creator>Kato, S</creator><creator>Yamaga, N</creator><creator>Ishibashi, A</creator><creator>Kani, K</creator><creator>Yakabi, K</creator><creator>Nagoshi, S</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20210527</creationdate><title>P596 Trough concentration of ustekinumab was a useful biomarker for the prediction of treatment-effects in patients with Crohn’s Diseases</title><author>Kato, S ; Yamaga, N ; Ishibashi, A ; Kani, K ; Yakabi, K ; Nagoshi, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c917-693d1b1c8bcea45b58e67c3f3eaf86a0bbd52babb7162d90f13cd2b80a5c77fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kato, S</creatorcontrib><creatorcontrib>Yamaga, N</creatorcontrib><creatorcontrib>Ishibashi, A</creatorcontrib><creatorcontrib>Kani, K</creatorcontrib><creatorcontrib>Yakabi, K</creatorcontrib><creatorcontrib>Nagoshi, S</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of Crohn's and colitis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kato, S</au><au>Yamaga, N</au><au>Ishibashi, A</au><au>Kani, K</au><au>Yakabi, K</au><au>Nagoshi, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P596 Trough concentration of ustekinumab was a useful biomarker for the prediction of treatment-effects in patients with Crohn’s Diseases</atitle><jtitle>Journal of Crohn's and colitis</jtitle><date>2021-05-27</date><risdate>2021</risdate><volume>15</volume><issue>Supplement_1</issue><spage>S543</spage><epage>S543</epage><pages>S543-S543</pages><issn>1873-9946</issn><eissn>1876-4479</eissn><doi>10.1093/ecco-jcc/jjab076.717</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1873-9946
ispartof Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S543-S543
issn 1873-9946
1876-4479
language eng
recordid cdi_crossref_primary_10_1093_ecco_jcc_jjab076_717
source Oxford Journals Online
title P596 Trough concentration of ustekinumab was a useful biomarker for the prediction of treatment-effects in patients with Crohn’s Diseases
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T02%3A46%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P596%20Trough%20concentration%20of%20ustekinumab%20was%20a%20useful%20biomarker%20for%20the%20prediction%20of%20treatment-effects%20in%20patients%20with%20Crohn%E2%80%99s%20Diseases&rft.jtitle=Journal%20of%20Crohn's%20and%20colitis&rft.au=Kato,%20S&rft.date=2021-05-27&rft.volume=15&rft.issue=Supplement_1&rft.spage=S543&rft.epage=S543&rft.pages=S543-S543&rft.issn=1873-9946&rft.eissn=1876-4479&rft_id=info:doi/10.1093/ecco-jcc/jjab076.717&rft_dat=%3Ccrossref%3E10_1093_ecco_jcc_jjab076_717%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c917-693d1b1c8bcea45b58e67c3f3eaf86a0bbd52babb7162d90f13cd2b80a5c77fa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true